- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Oncology
Volume 2010 (2010), Article ID 361836, 7 pages
doi:10.1155/2010/361836
Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises
1Division of Hematology and Oncology, Department of Medicine, The George Washington University Medical Center, 2150 Pennsylvania Avenue Northwest, Washington, DC 20037, USA
2Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
3Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Received 31 October 2009; Accepted 30 December 2009
Academic Editor: Arkadiusz Dudek
Copyright © 2010 Jeanny B. Aragon-Ching et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Jeanny B. Aragon-Ching, Ravi A. Madan, and William L. Dahut, “Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises,” Journal of Oncology, vol. 2010, Article ID 361836, 7 pages, 2010. doi:10.1155/2010/361836